No results for ‘’
Archit Organosys Ltd
₹67.90
(3.03%)
Wed, 16 Sept 2026, 05:43 pm
Process Industries
Chemicals: Specialty
24.5KArchit Organosys Ratios
| Particulars | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 10.24 | 4.50 | 7.37 | 5.41 | 4.85 | 6.52 | 8.83 | 116.56 | 0 | 0 | 7.43 | 9.73 | 10.92 | 26.60 | 15.19 |
| Price to book ratio | 0 | 1.08 | 0.83 | 0.90 | 0.68 | 0.70 | 1.17 | 2.70 | 1.50 | 0.55 | 0.26 | 0.92 | 1.54 | 2.01 | 1.38 | 1.11 |
| Price to sales ratio | 0 | 0.08 | 0.07 | 0.10 | 0.07 | 0.07 | 0.19 | 0.32 | 0.73 | 0.23 | 0.11 | 0.39 | 0.59 | 0.97 | 0.78 | 0.61 |
| Price to cash flow ratio | 0 | 0 | 0 | 2.37 | 6.74 | 4.12 | 220.38 | 8.83 | 0 | 0 | 1.68 | 4.42 | 9.17 | 8.23 | 10.16 | 4.07 |
| Enterprise value | 0 | 11.07Cr | 11.57Cr | 10.48Cr | 10.1Cr | 11.92Cr | 19.71Cr | 46Cr | 94.52Cr | 51.35Cr | 40.4Cr | 64.09Cr | 109Cr | 150Cr | 111Cr | 104Cr |
| Enterprise value to EBITDA ratio | 0 | 9 | 7.86 | 4.84 | 6.28 | 5.85 | 6.84 | 16.46 | 29.62 | 0 | 12.30 | 5.76 | 6.37 | 7.61 | 15.80 | 8.01 |
| Debt to equity ratio | 2.47 | 2.95 | 3.03 | 1.72 | 1.56 | 1.62 | 0.85 | 1.18 | 0.91 | 1.06 | 1.02 | 0.76 | 0.65 | 0.51 | 0.41 | 0.40 |
| Return on equity % | 0 | 11.24 | 20.43 | 13.15 | 13.42 | 15.47 | 15.82 | 8.65 | 1.54 | -12.66 | -2.32 | 13.41 | 17.81 | 19.97 | 5.30 | 7.58 |
Archit Organosys Ltd Ratios
The Archit Organosys Ltd Ratios page provides a complete fundamental analysis of Archit Organosys Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Archit Organosys Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.
Archit Organosys Ltd (NSE: , BSE: 524640) is currently trading at ₹67.90, with a market capitalization of ₹139.15Cr. As a major player in the Process industries sector and Chemicals: specialty industry, Archit Organosys Ltd remains a key stock for fundamental analysis using Archit Organosys Ltd Ratios.
Archit Organosys Ltd Ratios: Valuation Overview
Price to Earnings Ratio (P/E)
The Archit Organosys Ltd P/E ratio currently stands at 15.19, making it one of the most tracked metrics in Archit Organosys Ltd Ratios.
Historically, the Archit Organosys Ltd P/E ratio has shown strong fluctuations:
- 2024: 15.19
- 2023: 26.60
- 2022: 10.92
- 2021: 9.73
- 2020: 7.43
The decline in Archit Organosys Ltd P/E ratio suggests improving earnings relative to stock price.
Price to Book Ratio (P/B)
The Archit Organosys Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 1.11.
Historical P/B trend:
- 2024: 1.11
- 2023: 1.38
- 2022: 2.01
- 2021: 1.54
Archit Organosys Ltd shows reasonable valuation compared to its asset base.
Price to Sales Ratio (P/S)
The Archit Organosys Ltd P/S ratio currently stands at 0.61, an important part of Archit Organosys Ltd Ratios for revenue valuation.
Historical P/S ratio:
- 2024: 0.61
- 2023: 0.78
- 2022: 0.97
- 2021: 0.59
A stable or declining Archit Organosys Ltd P/S ratio indicates cautious market sentiment.
Archit Organosys Ltd Price to Cash Flow Ratio (P/CF)
The Archit Organosys Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 4.07.
Historical Archit Organosys Ltd Price to Cash Flow Ratio:
- 2024: 4.07
- 2023: 10.16
- 2022: 8.23
- 2021: 9.17
- 2020: 4.42
The declining Archit Organosys Ltd Price to Cash Flow Ratio suggests improving cash flow strength.
Archit Organosys Ltd Enterprise Value Ratios
Enterprise Value (EV)
The Archit Organosys Ltd EV currently stands at ₹104Cr, representing the total company valuation including debt.
Historical EV trend:
- 2024: 104Cr
- 2023: 111Cr
- 2022: 150Cr
- 2021: 109Cr
Archit Organosys Ltd enterprise value consolidation suggests stable valuation.
EV/EBITDA Ratio
The Archit Organosys Ltd EV/EBITDA ratio is currently 8.01, a key metric in Archit Organosys Ltd Ratios to assess valuation relative to earnings.
Historical EV/EBITDA:
- 2024: 8.01
- 2023: 15.80
- 2022: 7.61
- 2021: 6.37
Stable Archit Organosys Ltd EV/EBITDA indicates balanced valuation.
Archit Organosys Ltd Financial Strength Ratios
Debt to Equity Ratio (D/E)
The Archit Organosys Ltd D/E ratio is currently 0.40, reflecting leverage and financial stability.
Historical D/E:
- 2024: 0.40
- 2023: 0.41
- 2022: 0.51
- 2021: 0.65
Archit Organosys Ltd maintains a strong balance sheet with low debt levels.
Return on Equity (ROE %)
The Archit Organosys Ltd ROE currently stands at 7.58%, showing profitability and capital efficiency.
Historical ROE:
- 2024: 7.58
- 2023: 5.30
- 2022: 19.97
- 2021: 17.81
Declining ROE indicates pressure on profitability.
Archit Organosys Ltd Ratios Analysis Summary
The Archit Organosys Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Archit Organosys Ltd stock is undervalued, fairly valued, or overvalued.
Tracking Archit Organosys Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.